30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Akero Therapeutics Inc (AKRO)

Track

Stock chart
Ticker: AKRO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Cheng Andrew
President and CEO
1 sale — total 1,619,340 USD
Planned sale 10 Oct 2025
Value US$3,062,553.51 | Price 113.80 | Shares 83,338
Planned sale 7 Oct 2025
Value US$2,761,342.59 | Price 449.07 | Shares 77,941
Planned sale 7 Oct 2025
Value US$2,152,866.88 | Price 321.29 | Shares 21,281
Proposed sale 7 Oct 2025
Value US$2,595,229.00 | Price 46.04 | Shares 56,369
Planned sale 1 Oct 2025
Value US$201,580.78 | Price 47.98 | Shares 4,201
Planned sale 1 Oct 2025
Value US$395,397.56 | Price 47.64 | Shares 8,299
Sale 11 Sep 2025
Value US$25,209.72 | Price 43.02 | Shares 586
Sale 11 Sep 2025
Value US$28,350.18 | Price 43.02 | Shares 659
Sale 11 Sep 2025
Value US$77,263.92 | Price 43.02 | Shares 1,796
Sale 11 Sep 2025
Value US$28,350.18 | Price 43.02 | Shares 659
Sale 11 Sep 2025
Value US$23,790.06 | Price 43.02 | Shares 553
Planned sale 10 Sep 2025
Value US$7,049.96 | Price 44.62 | Shares 158
Planned sale 10 Sep 2025
Value US$321,911.42 | Price 44.00 | Shares 7,317
Planned sale 10 Sep 2025
Value US$968,439.85 | Price 42.99 | Shares 22,525
Proposed sale 10 Sep 2025
Value US$4,015,800.00 | Price 44.62 | Shares 90,000
Planned sale 8 Sep 2025
Value US$1,525.75 | Price 44.88 | Shares 34
Planned sale 8 Sep 2025
Value US$550,610.75 | Price 44.17 | Shares 12,466
Planned sale 2 Sep 2025
Value US$2,902.38 | Price 47.58 | Shares 61
Planned sale 2 Sep 2025
Value US$129,105.50 | Price 47.14 | Shares 2,739
Planned sale 2 Sep 2025
Value US$444,027.20 | Price 45.78 | Shares 9,700
Planned sale 12 Aug 2025
Value US$65,189.08 | Price 48.32 | Shares 1,349
Planned sale 12 Aug 2025
Value US$532,136.87 | Price 47.72 | Shares 11,151
Proposed sale 12 Aug 2025
Value US$2,414,000.00 | Price 48.28 | Shares 50,000
Proposed sale 12 Aug 2025
Value US$142,371.90 | Price 47.46 | Shares 3,000
Sale 12 Aug 2025
Value US$142,371.00 | Price 47.46 | Shares 3,000
Planned sale 11 Aug 2025
Value US$19,774.00 | Price 49.44 | Shares 400
Planned sale 11 Aug 2025
Value US$918,906.32 | Price 48.87 | Shares 18,805
Planned sale 11 Aug 2025
Value US$518,915.65 | Price 48.07 | Shares 10,795
Planned sale 5 Aug 2025
Value US$344,577.23 | Price 49.49 | Shares 6,962
Planned sale 5 Aug 2025
Value US$271,721.97 | Price 49.07 | Shares 5,538
Planned sale 16 Jul 2025
Value US$71,762.11 | Price 53.47 | Shares 1,342
Planned sale 16 Jul 2025
Value US$457,705.17 | Price 52.87 | Shares 8,658
Planned sale 10 Jul 2025
Value US$792,223.85 | Price 51.73 | Shares 15,314
Planned sale 10 Jul 2025
Value US$742,671.02 | Price 50.57 | Shares 14,686
Planned sale 7 Jul 2025
Value US$2,157.30 | Price 52.62 | Shares 41
Planned sale 7 Jul 2025
Value US$94,892.70 | Price 52.00 | Shares 1,825
Planned sale 7 Jul 2025
Value US$541,610.89 | Price 50.93 | Shares 10,634
Proposed sale 7 Jul 2025
Value US$2,916,563.00 | Price 51.85 | Shares 56,250
Planned sale 1 Jul 2025
Value US$105,760.00 | Price 52.88 | Shares 2,000
Proposed sale 1 Jul 2025
Value US$106,720.00 | Price 53.36 | Shares 2,000
Sale 20 Jun 2025
Value US$47,766.25 | Price 54.59 | Shares 875
Sale 18 Jun 2025
Value US$89,553.72 | Price 54.84 | Shares 1,633
Sale 18 Jun 2025
Value US$89,608.56 | Price 54.84 | Shares 1,634
Sale 18 Jun 2025
Value US$79,682.52 | Price 54.84 | Shares 1,453
Sale 18 Jun 2025
Value US$46,504.32 | Price 54.84 | Shares 848
Sale 18 Jun 2025
Value US$61,914.36 | Price 54.84 | Shares 1,129
Sale 18 Jun 2025
Value US$363,040.80 | Price 54.84 | Shares 6,620
Planned sale 16 Jun 2025
Value US$49,689.50 | Price 55.52 | Shares 895
Planned sale 16 Jun 2025
Value US$158,643.10 | Price 54.80 | Shares 2,895
Planned sale 16 Jun 2025
Value US$333,973.80 | Price 53.78 | Shares 6,210
Planned sale 16 Jun 2025
Value US$27,546.00 | Price 55.09 | Shares 500
Planned sale 16 Jun 2025
Value US$80,725.50 | Price 53.82 | Shares 1,500
Sale 10 Jun 2025
Value US$134,604.55 | Price 53.99 | Shares 2,493
Sale 10 Jun 2025
Value US$151,401.98 | Price 54.00 | Shares 2,804
Sale 10 Jun 2025
Value US$127,322.57 | Price 54.00 | Shares 2,358
Sale 10 Jun 2025
Value US$49,625.08 | Price 54.00 | Shares 919
Sale 10 Jun 2025
Value US$423,150.98 | Price 53.99 | Shares 7,837
Planned sale 10 Jun 2025
Value US$823,882.77 | Price 54.35 | Shares 15,158
Planned sale 10 Jun 2025
Value US$797,905.92 | Price 53.76 | Shares 14,842
Sale 10 Jun 2025
Value US$151,350.79 | Price 54.00 | Shares 2,803
Planned sale 6 Jun 2025
Value US$1,376,000.00 | Price 55.04 | Shares 25,000
Planned sale 5 Jun 2025
Value US$169,596.00 | Price 53.84 | Shares 3,150
Planned sale 5 Jun 2025
Value US$499,037.55 | Price 53.37 | Shares 9,350
Planned sale 2 Jun 2025
Value US$5,104.00 | Price 51.04 | Shares 100
Planned sale 2 Jun 2025
Value US$166,514.70 | Price 50.46 | Shares 3,300
Planned sale 2 Jun 2025
Value US$29,638.80 | Price 49.40 | Shares 600
Planned sale 22 May 2025
Value US$200,000.00 | Price 50.00 | Shares 4,000
Proposed sale 22 May 2025
Value US$483,500.00 | Price 48.35 | Shares 10,000
Planned sale 15 May 2025
Value US$174,947.90 | Price 39.91 | Shares 4,384
Planned sale 15 May 2025
Value US$109,659.34 | Price 39.46 | Shares 2,779
Planned sale 15 May 2025
Value US$108,370.56 | Price 38.20 | Shares 2,837
Proposed sale 15 May 2025
Value US$1,136,400.00 | Price 37.88 | Shares 30,000
Planned sale 12 May 2025
Value US$949,255.20 | Price 41.63 | Shares 22,800
Planned sale 12 May 2025
Value US$295,200.00 | Price 41.00 | Shares 7,200
Proposed sale 12 May 2025
Value US$4,782,000.00 | Price 39.85 | Shares 120,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-14 2025-10-10 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
83,338 +30.9%
113.80
US$3,062,554 		83,338 +30.9% 113.80 US$3,062,554
2025-10-09 2025-10-07 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
77,941 -29.8%
449.07
US$2,761,343 		77,941 -29.8% 449.07 US$2,761,343
2025-10-09 2025-10-07 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
21,281 +47.3%
321.29
US$2,152,867 		21,281 +47.3% 321.29 US$2,152,867
2025-10-07 2025-10-07 PrS Proposed sale
4.1
Timothy Rolph

Officer

Officer
56,369
46.04
US$2,595,229 		56,369 46.04 US$2,595,229
2025-10-03 2025-10-01 PlS Planned sale
1.8
Young Jonathan

Chief Operating Officer

Officer
4,201 -2.1%
47.98
US$201,581 		4,201 -2.1% 47.98 US$201,581
2025-10-03 2025-10-01 PlS Planned sale
1.8
Young Jonathan

Chief Operating Officer

Officer
8,299 -4.0%
47.64
US$395,398 		8,299 -4.0% 47.64 US$395,398
2025-09-12 2025-09-11 S Sale
1.8
Young Jonathan

Chief Operating Officer

Officer
586 -0.3%
43.02
US$25,210 		586 -0.3% 43.02 US$25,210
2025-09-12 2025-09-11 S Sale
3.8
White William Richard

Chief Financial Officer

Officer
659 -1.1%
43.02
US$28,350 		659 -1.1% 43.02 US$28,350
2025-09-12 2025-09-11 S Sale
3.3
Cheng Andrew

President and CEO

Executive Director
1,796 -0.4%
43.02
US$77,264 		1,796 -0.4% 43.02 US$77,264
2025-09-12 2025-09-11 S Sale
4.0
Yale Catriona

Chief Development Officer

Officer
659 -0.7%
43.02
US$28,350 		659 -0.7% 43.02 US$28,350
2025-09-12 2025-09-11 S Sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
553 -0.3%
43.02
US$23,790 		553 -0.3% 43.02 US$23,790
2025-09-12 2025-09-10 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
158 -0.0%
44.62
US$7,050 		158 -0.0% 44.62 US$7,050
2025-09-12 2025-09-10 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
7,317 -1.5%
44.00
US$321,911 		7,317 -1.5% 44.00 US$321,911
2025-09-12 2025-09-10 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
22,525 -4.5%
42.99
US$968,440 		22,525 -4.5% 42.99 US$968,440
2025-09-10 2025-09-10 PrS Proposed sale
3.3
Andrew Cheng

President, CEO and Director

Non-Executive Director
90,000
44.62
US$4,015,800 		90,000 44.62 US$4,015,800
2025-09-10 2025-09-08 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
34 -0.0%
44.88
US$1,526 		34 -0.0% 44.88 US$1,526
2025-09-10 2025-09-08 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
12,466 -6.9%
44.17
US$550,611 		12,466 -6.9% 44.17 US$550,611
2025-09-04 2025-09-02 PlS Planned sale
1.8
Young Jonathan

Chief Operating Officer

Officer
61 -0.0%
47.58
US$2,902 		61 -0.0% 47.58 US$2,902
2025-09-04 2025-09-02 PlS Planned sale
1.8
Young Jonathan

Chief Operating Officer

Officer
2,739 -1.4%
47.14
US$129,106 		2,739 -1.4% 47.14 US$129,106
2025-09-04 2025-09-02 PlS Planned sale
1.8
Young Jonathan

Chief Operating Officer

Officer
9,700 -4.6%
45.78
US$444,027 		9,700 -4.6% 45.78 US$444,027
2025-08-13 2025-08-12 PlS Planned sale
1.8
Young Jonathan

Chief Operating Officer

Officer
1,349 -0.7%
48.32
US$65,189 		1,349 -0.7% 48.32 US$65,189
2025-08-13 2025-08-12 PlS Planned sale
1.8
Young Jonathan

Chief Operating Officer

Officer
11,151 -5.3%
47.72
US$532,137 		11,151 -5.3% 47.72 US$532,137
2025-08-12 2025-08-12 PrS Proposed sale
1.8
Jonathan Young

Officer

Officer
50,000
48.28
US$2,414,000 		50,000 48.28 US$2,414,000
2025-08-12 2025-08-12 PrS Proposed sale
3.6
JANE HENDERSON

Director

Non-Executive Director
3,000
47.46
US$142,372 		3,000 47.46 US$142,372
2025-08-12 2025-08-12 S Sale
3.6
Henderson Jane
Non-Executive Director
3,000 -24.2%
47.46
US$142,371 		3,000 -24.2% 47.46 US$142,371
2025-08-13 2025-08-11 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
400 -0.1%
49.44
US$19,774 		400 -0.1% 49.44 US$19,774
2025-08-13 2025-08-11 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
18,805 -3.7%
48.87
US$918,906 		18,805 -3.7% 48.87 US$918,906
2025-08-13 2025-08-11 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
10,795 -2.1%
48.07
US$518,916 		10,795 -2.1% 48.07 US$518,916
2025-08-07 2025-08-05 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
6,962 -4.0%
49.49
US$344,577 		6,962 -4.0% 49.49 US$344,577
2025-08-07 2025-08-05 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
5,538 -3.1%
49.07
US$271,722 		5,538 -3.1% 49.07 US$271,722
2025-07-18 2025-07-16 PlS Planned sale
4.0
Yale Catriona

Chief Development Officer

Officer
1,342 -1.4%
53.47
US$71,762 		1,342 -1.4% 53.47 US$71,762
2025-07-18 2025-07-16 PlS Planned sale
4.0
Yale Catriona

Chief Development Officer

Officer
8,658 -8.5%
52.87
US$457,705 		8,658 -8.5% 52.87 US$457,705
2025-07-11 2025-07-10 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
15,314 -2.9%
51.73
US$792,224 		15,314 -2.9% 51.73 US$792,224
2025-07-11 2025-07-10 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
14,686 -2.7%
50.57
US$742,671 		14,686 -2.7% 50.57 US$742,671
2025-07-09 2025-07-07 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
41 -0.0%
52.62
US$2,157 		41 -0.0% 52.62 US$2,157
2025-07-09 2025-07-07 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
1,825 -1.1%
52.00
US$94,893 		1,825 -1.1% 52.00 US$94,893
2025-07-09 2025-07-07 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
10,634 -5.9%
50.93
US$541,611 		10,634 -5.9% 50.93 US$541,611
2025-07-07 2025-07-07 PrS Proposed sale
4.1
Timothy Rolph

Officer

Officer
56,250
51.85
US$2,916,563 		56,250 51.85 US$2,916,563
2025-07-03 2025-07-01 PlS Planned sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
2,000 -6.3%
52.88
US$105,760 		2,000 -6.3% 52.88 US$105,760
2025-07-01 2025-07-01 PrS Proposed sale
3.2
PATRICK D LAMY

Officer

Officer
2,000
53.36
US$106,720 		2,000 53.36 US$106,720
2025-06-20 2025-06-20 S Sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
875 -2.7%
54.59
US$47,766 		875 -2.7% 54.59 US$47,766
2025-06-20 2025-06-18 S Sale
4.0
Yale Catriona

Chief Development Officer

Officer
1,633 -1.8%
54.84
US$89,554 		1,633 -1.8% 54.84 US$89,554
2025-06-20 2025-06-18 S Sale
3.8
White William Richard

Chief Financial Officer

Officer
1,634 -2.8%
54.84
US$89,609 		1,634 -2.8% 54.84 US$89,609
2025-06-20 2025-06-18 S Sale
1.8
Young Jonathan

Chief Operating Officer

Officer
1,453 -0.7%
54.84
US$79,683 		1,453 -0.7% 54.84 US$79,683
2025-06-20 2025-06-18 S Sale
2.9
Gangloff Scott A.

Chief Technology Officer

Officer
848 -3.5%
54.84
US$46,504 		848 -3.5% 54.84 US$46,504
2025-06-20 2025-06-18 S Sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
1,129 -0.7%
54.84
US$61,914 		1,129 -0.7% 54.84 US$61,914
2025-06-20 2025-06-18 S Sale
3.3
Cheng Andrew

President and CEO

Executive Director
6,620 -1.2%
54.84
US$363,041 		6,620 -1.2% 54.84 US$363,041
2025-06-20 2025-06-16 PlS Planned sale
4.0
Yale Catriona

Chief Development Officer

Officer
895 -1.0%
55.52
US$49,690 		895 -1.0% 55.52 US$49,690
2025-06-20 2025-06-16 PlS Planned sale
4.0
Yale Catriona

Chief Development Officer

Officer
2,895 -3.0%
54.80
US$158,643 		2,895 -3.0% 54.80 US$158,643
2025-06-20 2025-06-16 PlS Planned sale
4.0
Yale Catriona

Chief Development Officer

Officer
6,210 -6.1%
53.78
US$333,974 		6,210 -6.1% 53.78 US$333,974
2025-06-20 2025-06-16 PlS Planned sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
500 -1.5%
55.09
US$27,546 		500 -1.5% 55.09 US$27,546
2025-06-20 2025-06-16 PlS Planned sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
1,500 -4.3%
53.82
US$80,726 		1,500 -4.3% 53.82 US$80,726
2025-06-12 2025-06-10 S Sale
1.8
Young Jonathan

Chief Operating Officer

Officer
2,493 -1.2%
53.99
US$134,605 		2,493 -1.2% 53.99 US$134,605
2025-06-12 2025-06-10 S Sale
3.8
White William Richard

Chief Financial Officer

Officer
2,804 -4.5%
54.00
US$151,402 		2,804 -4.5% 54.00 US$151,402
2025-06-12 2025-06-10 S Sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
2,358 -1.4%
54.00
US$127,323 		2,358 -1.4% 54.00 US$127,323
2025-06-12 2025-06-10 S Sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
919 -2.7%
54.00
US$49,625 		919 -2.7% 54.00 US$49,625
2025-06-12 2025-06-10 S Sale
3.3
Cheng Andrew

President and CEO

Executive Director
7,837 -1.4%
53.99
US$423,151 		7,837 -1.4% 53.99 US$423,151
2025-06-12 2025-06-10 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
15,158 -2.6%
54.35
US$823,883 		15,158 -2.6% 54.35 US$823,883
2025-06-12 2025-06-10 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
14,842 -2.5%
53.76
US$797,906 		14,842 -2.5% 53.76 US$797,906
2025-06-12 2025-06-10 S Sale
4.0
Yale Catriona

Chief Development Officer

Officer
2,803 -2.9%
54.00
US$151,351 		2,803 -2.9% 54.00 US$151,351
2025-06-09 2025-06-06 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
25,000 -12.8%
55.04
US$1,376,000 		25,000 -12.8% 55.04 US$1,376,000
2025-06-09 2025-06-05 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
3,150 -1.8%
53.84
US$169,596 		3,150 -1.8% 53.84 US$169,596
2025-06-09 2025-06-05 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
9,350 -5.1%
53.37
US$499,038 		9,350 -5.1% 53.37 US$499,038
2025-06-04 2025-06-02 PlS Planned sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
100 -0.3%
51.04
US$5,104 		100 -0.3% 51.04 US$5,104
2025-06-04 2025-06-02 PlS Planned sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
3,300 -8.9%
50.46
US$166,515 		3,300 -8.9% 50.46 US$166,515
2025-06-04 2025-06-02 PlS Planned sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
600 -1.6%
49.40
US$29,639 		600 -1.6% 49.40 US$29,639
2025-05-23 2025-05-22 PlS Planned sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
4,000 -10.7%
50.00
US$200,000 		4,000 -10.7% 50.00 US$200,000
2025-05-22 2025-05-22 PrS Proposed sale
3.2
PATRICK D LAMY

Officer

Officer
10,000
48.35
US$483,500 		10,000 48.35 US$483,500
2025-05-19 2025-05-15 PlS Planned sale
4.0
Yale Catriona

Chief Development Officer

Officer
4,384 -4.4%
39.91
US$174,948 		4,384 -4.4% 39.91 US$174,948
2025-05-19 2025-05-15 PlS Planned sale
4.0
Yale Catriona

Chief Development Officer

Officer
2,779 -2.7%
39.46
US$109,659 		2,779 -2.7% 39.46 US$109,659
2025-05-19 2025-05-15 PlS Planned sale
4.0
Yale Catriona

Chief Development Officer

Officer
2,837 -2.7%
38.20
US$108,371 		2,837 -2.7% 38.20 US$108,371
2025-05-15 2025-05-15 PrS Proposed sale
4.0
CATRIONA YALE

Officer

Officer
30,000
37.88
US$1,136,400 		30,000 37.88 US$1,136,400
2025-05-13 2025-05-12 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
22,800 -3.7%
41.63
US$949,255 		22,800 -3.7% 41.63 US$949,255
2025-05-13 2025-05-12 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
7,200 -1.2%
41.00
US$295,200 		7,200 -1.2% 41.00 US$295,200
2025-05-12 2025-05-12 PrS Proposed sale
3.3
Andrew Cheng

Officer

Officer
120,000
39.85
US$4,782,000 		120,000 39.85 US$4,782,000
Explore more

More insider trading research around Akero Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America